FDA Commissioner Scott Gottlieb, M.D., is embarking on a series of initiatives aimed directly at bringing down rising drug prices, specifically for “complex…

The generic drug industry's effort for relief against Maryland pricing regulations has come up short, at least for now.

Rep. Elijah Cummings, D-Md., is urging President Trump to press for lower prices on Biogen's multiple sclerosis drug Zinbryta.

It didn't take long for Congress to push back at Allergan's first-of-a-kind patent deal with the Saint Regis Mohawk Tribe.

Gilead Sciences has received approval for Sovaldi from China's FDA, gaining a foothold in the world's largest hepatitis C market.

Allergan says CFO Tessa Hilado, which came to Allergan three years ago, is retiring but agreed to stay on until her replacement is named.

AbbVie is thinking about reneging on its 10% price-hike limit announced in January, executives said in a recent meeting with analysts.

Pfizer and Merck KGaA’s Bavencio, which won an FDA nod for Merkel cell carcinoma in March, has now been approved in Europe to treat that cancer.

Regulatory